Skip to main content

Advertisement

Table 2 Baseline characteristics

From: A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis

Parameter Treatment group (N = 14) Placebo group (N = 14)
Age (years; Mean ± SD) 37.2 ± 9.40 45.8 ± 12.26
Gender (Male:Female) 9:5 11:3
Height (cm; Mean ± SD) 165.2 ± 7.06 168.4 ± 5.45
Weight (kg; Mean ± SD) 63.3 ± 8.59 68.0 ± 9.32
Asian Race (N) 14 (100%) 14 (100%)
KOH Smear positive 14 (100%) 14 (100%)
Fungal culture positive 14 (100%) 14 (100%)
Live spore count positive 14 (100%) 14 (100%)
Type of Tinea and causative organism
 Tinea cruris 5 1
  Epidermophyton floccosum 3 0
  Trichophyton violaceum 1 1
  Trichophyton rubrum 1 0
 Tinea corporis 2 4
  Epidermophyton floccosum 1 1
  Trichophyton violaceum 0 1
  Trichophyton rubrum 1 2
 Tinea pedis 2 4
  Epidermophyton floccosum 2 4
  Trichophyton violaceum 0 0
  Trichophyton rubrum 0 0
Causative organism for Onychomycosis
 Epidermophyton floccosum 1 2
 Trichophyton mentagrophytes 2 2
 Trichophyton rubrum 2 1
Severity score
 Tinea (Mean ± SD) 9.0 ± 0.5 8.9 ± 0.6
 Size of lesion in subjects with Tinea (cm; Mean ± SD) 13.3 ± 5.1 8.0 ± 1.4
 Onychomycosis (Mean ± SD) 3.0 ± 0.0 3.0 ± 0.0
 Surface area affected in Onychomycosis (%; Mean ± SD) 63.0 ± 4.5 66.0 ± 5.5
  1. SD Standard deviation, cm Centimetre, KOH Potassium hydroxide